中文網
Taipei
Tue, Jun 28, 2022
20:03
mostly cloudy
30°C
CONNECT WITH US
Related company info
Shawn Chen, Taipei; Jessie Shen, DIGITIMES
Thursday 30 March 2006
  • Biostar Microtech International
  • Performance
    The company's stock price closed at NT$15.95 on the TSE on Monday, June 27, 2022.
    The company has reported consolidated revenues of NT$167 million for May 2022, representing a 5.3% drop on month and 31.7% drop on year.
    For the first quarter of 2022, the company totaled NT$691 million in consolidated revenues, down 19.9% sequentially and up 16% on year.
    Brief

    Full name: Biostar Microtech International

    Chinese name: 映泰股份有限公司

    Short name: Biostar

    Stock code: 2399

    Tax ID: 23826200

    Market: TSE

    Established: 29 Aug 1990

    Paid in capital: NT$1.78 billion

    Listed on TSE: 16 Dec 1999

    Website: www.biostar.com.tw

  • On display

    Biostar iMiner series

    Biostar G41 chipset motherboard

    Biostar TA790GX A3+ motherboard

  • Latest stock
    Biostar [2399] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    28-Jun 552 297 8,644,435 16.00 16.00 15.50 15.65-0.30-1.88% 15.60 15.65
    27-Jun 891 424 14,166,021 15.60 16.05 15.55 15.95+0.70+4.59% 15.90 15.95
    24-Jun 522 316 8,062,050 15.40 15.60 15.20 15.25+0.15+0.99% 15.25 15.30
    23-Jun 801 422 12,215,068 15.50 15.60 14.85 15.10-0.05-0.33% 15.05 15.10
    22-Jun 933 438 14,376,652 15.90 16.00 15.05 15.15-0.75-4.72% 15.15 15.20
    21-Jun 1,067 590 16,594,256 15.05 15.95 15.05 15.90+0.95+6.35% 15.85 15.90
    20-Jun 1,551 805 23,869,800 16.00 16.10 14.95 14.95-1.00-6.27% 14.95 15.00
    • Source: TSE, compiled by Digitimes
    Latest sales

    Biostar: Consolidated revenues, May 2021 - May 2022 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    May-22

    167

    (5.3%)

    (31.7%)

    1,034

    (1.7%)

    Apr-22

    176

    (11.3%)

    (16.9%)

    867

    7.4%

    Mar-22

    199

    (0.6%)

    (14.7%)

    691

    16%

    Feb-22

    200

    (31.7%)

    32.4%

    492

    35.7%

    Jan-22

    292

    9.7%

    38%

    292

    38%

    Dec-21

    267

    (25.5%)

    65.2%

    2,775

    24.6%

    Nov-21

    358

    50.4%

    77.4%

    2,508

    21.5%

    Oct-21

    238

    8.1%

    1.6%

    2,150

    15.4%

    Sep-21

    220

    (20.7%)

    (21.7%)

    1,912

    17.4%

    Aug-21

    278

    52.4%

    27.4%

    1,692

    25.6%

    Jul-21

    182

    1%

    (3.1%)

    1,415

    25.2%

    Jun-21

    180

    (26.2%)

    51.1%

    1,232

    30.8%

    May-21

    244

    15.3%

    60.5%

    1,052

    27.9%

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, June 2022

    Biostar: Consolidated revenues, 1Q21 - 1Q22 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    1Q-22

    691

    (19.9%)

    16%

    691

    16%

    4Q-21

    863

    26.9%

    44.4%

    2,775

    31.9%

    3Q-21

    680

    6.8%

    (1%)

    1,912

    26.9%

    2Q-21

    637

    6.9%

    57.5%

    1,232

    50.3%

    1Q-21

    596

    (0.3%)

    43.2%

    596

    43.2%

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, June 2022

    Latest balance sheet and income statement

    Biostar: Consolidated balance sheet, 1Q21 - 1Q22 (NT$k)

    Item

    1Q-2022

    4Q-2021

    3Q-2021

    2Q-2021

    1Q-2021

    Current assets

    2,702,269

    2,744,806

    2,455,726

    2,467,669

    2,407,387

    Non-current assets

    549,171

    551,013

    542,443

    547,876

    445,063

    Assets

    3,251,440

    3,295,819

    2,998,169

    3,015,545

    2,852,450

    Current liabilities

    744,934

    830,639

    616,241

    623,828

    600,781

    Non-current liabilities

    36,663

    33,777

    34,166

    34,179

    34,748

    Liabilities

    781,597

    864,416

    650,407

    658,007

    635,529

    Stockholders' equity

    2,469,843

    2,431,403

    2,347,762

    2,357,538

    2,216,921

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, June 2022

    Biostar: Consolidated income statement, 1Q21 - 1Q22 (NT$k)

    Item

    1Q-2022

    4Q-2021

    3Q-2021

    2Q-2021

    1Q-2021

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Operating revenue

    690,764

     

    862,532

     

    679,932

     

    636,806

     

    595,526

     

    Gross profit (loss) from operations

    121,302

    17.6%

    147,157

    17.1%

    133,325

    19.6%

    145,325

    22.8%

    94,326

    15.8%

    Operating expenses

    73,568

    10.7%

    63,488

    7.4%

    78,260

    11.5%

    88,444

    13.9%

    73,227

    12.3%

    Operating income (loss)

    47,734

    6.9%

    83,669

    9.7%

    55,065

    8.1%

    56,881

    8.9%

    21,099

    3.5%

    Non-operating expenses and losses

    4,570

    0.7%

    10,479

    1.2%

    13,462

    2%

    113,744

    17.9%

    52,442

    8.8%

    Income from continuing operations before income tax

    52,304

    7.6%

    94,148

    10.9%

    68,527

    10.1%

    170,625

    26.8%

    73,541

    12.3%

    Net income (loss)

    37,904

    5.5%

    86,733

    10.1%

    58,468

    8.6%

    147,696

    23.2%

    68,778

    11.5%

    Diluted earnings per share (NT$)

    0.2

     

    0.5

     

    0.3

     

    0.8

     

    0.4

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, June 2022

Realtime news

Taiwan notebooks - 4Q 2021

Global server revenue forecast, 2022

Global server shipment forecast, 2022

South Korea to build semiconductor ecosystem; Tianma to invest in 8.6-gen panel project; Nissan and Honda unveil EV development plans

Advanced packaging technology outlook, 2020-2026

Smart manufacturing progress of Taiwan, 2021